Susan E. Abbatiello
The Broad Institute of MIT and Harvard, Cambridge, USA

Susan E. Abbatiello is a Research Scientist at the Proteomics Platform at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts.  She received a B.A. in Chemistry at the College of the Holy Cross in Worcester, Massachusetts, then spent five years working at Genetics Institute (currently Wyeth Biopharma) developing LC-based assays for protein pharmaceuticals.  She earned her Ph.D. in Analytical Chemistry at the University of Florida in the lab of John Eyler, specializing in mass spectrometric characterization and quantitation of a suspected leukemia biomarker.  Her postdoctoral training was in the lab of Thomas P. Conrads at the University of Pittsburgh, where her work continued in peptide quantitation using isotope dilution (ID) and multiple reaction monitoring (MRM) mass spectrometry (MS) in different areas of cancer research.

Dr. Abbatiello is the co-chair of the Verification Working Group, part of the National Cancer Institute’s Clinical Proteomics Technology Assessment for Cancer (CPTAC) initiative.  The efforts of this group concentrate on establishing rigorous protocols, reagents, methodologies, and software for reproducible quantitation of cancer-relevant protein targets in plasma using ID-MRM-MS, which can be made available to the proteomics community.  Dr. Abbatiello is a member of the American Society for Mass Spectrometry and the American Association for Cancer Research.